Routine NavDx® testing to track changes in your TTMV® Score offers you and your provider a
more complete picture of your HPV-positive (HPV+) cancer status than imaging scans alone
Recurrence Monitoring
Detect recurrences a median of 4 months earlier than imaging or physical exam
Pretreatment
Confirm the HPV genotype and baseline TTMV-HPV DNA Score
During Treatment
Track changes in TTMV Scores to assess response to treatment and determine if cancer is still present
TTMV®-HPV DNA
Tumor tissue modified viral (TTMV)-HPV DNA, is a unique human papillomavirus (HPV)-driven cancer biomarker that dying tumor cells shed into the blood

- TTMV-HPV DNA is found in people with HPV positive (HPV+) cancers, like those of the throat or mouth (oropharyngeal cancer) and anal cancer, making it an ideal biomarker
- Measuring and tracking your blood TTMV Scores gives physicians valuable information about the status of your HPV+ cancer
Getting started with the NavDx test is easy
Start the
conversation with your provider
Order NavDx tests for your HPV+ cancer patients
Serial testing assures earlier detection of residual/recurrent disease
Stay
Connected
Sign up for updates on the latest developments in HPV+cancer detection and monitoring
We’re here to help!
Frequently Asked Questions (FAQs)
Get the answers to the most common questions regarding NavDx testing and related topics
Contact Us
To connect with Naveris Client Services, please email us at support@naveris.com, or call directly at (833) 628-3747 with any questions